Obstructive hypertrophic cardiomyopathy (HCM) often causes debilitating symptoms that traditional beta-blockers and calcium channel blockers fail to adequately control, leaving many patients at risk for persistent functional limitations. This activity addresses critical gaps in recognizing when to escalate care and how to integrate advanced therapies into clinical practice to improve patient quality of life. Learners will explore the role of cardiac myosin inhibitors, such as mavacamten and aficamten, which target the underlying pathophysiology of HCM to reduce obstruction and the need for invasive procedures. The program provides practical guidance on individualizing treatment, navigating REMS program requirements, and incorporating essential patient-centered strategies like genetic counseling and shared decision-making.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
36 of 36 courses listed here are free.
Collected from the provider’s public pages · source
Top 6 courses
-
-
-
-
-
-
Reflux Red Flags, and the Referral Riddle
0.25 Credits
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Dermatology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Hematology
- Interventional Cardiology
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neurology
- Ophthalmology
- Pulmonary Disease
- Rheumatology
- Surgical Oncology
- Cardio-Vascular
- Emergency & Critical Care
- GI & Liver
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- Commercial Support
-
ReleasedJun 24, 2026
-
Last day to claim creditJun 25, 2027 9 months left
-
Global Learning Collaborative Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
-
touchIME +1 Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies
-
Learner’s Digest International (TM) Evaluation and Treatment of Hypertrophic Cardiomyopathy
-
National Association for Continuing Education Conversations in Cardiology – Recurrent MI: Are You Using the Best Prevention Strategies?
-
National Association for Continuing Education The Cortisol Connection: Screening and Targeted Therapy
-
National Association for Continuing Education From Gaps to Gains: Guiding HFmrEF and HFpEF Care
